[THERAPY OF IATROGENIC LEUKOPENIAS DUE TO CHEMO-RADIOTHERAPEUTIC ASSOCIATION BY MEANS OF ORAL LYSOZYME].
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D006801:Humans; D007049:Iatrogenic Disease; D007960:Leukocyte Disorders; D007970:Leukopenia; D009113:Muramidase; D009369:Neoplasms / Q000532:radiotherapy*; D011837:Radiation-Protective Agents; D014116:Toxicology
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D011837:Radiation-Protective Agents; D009113:Muramidase
ANTINEOPLASTIC AGENTS; LEUKOPENIA; MURAMIDASE; NEOPLASM RADIOTHERAPY; RADIATION-PROTECTIVE AGENTS; TOXICOLOGIC REPORT
TERAPIA DELLE LEUCOPENIE IATROGENE DA ASSOCIAZIONE CHEMIO-RADIOTERAPICA MEDIANTE LISOZIMA PER VIA ORALE.